Table 6.
Clinical importance and interest in participating study
| No. (%) | |||
|---|---|---|---|
| |
Any reduction at all |
15 |
(21.7%) |
| Amount an alternative antibiotic drug and regimen needs to reduce infection rate before the improvement is considered "clinically important" |
5% |
10 |
(14.5%) |
| 10% |
15 |
(21.7%) |
|
| 15% |
4 |
(5.8%) |
|
| 20% |
12 |
(17.4%) |
|
| 25% |
8 |
(11.6%) |
|
| 30% |
1 |
(1.4%) |
|
| 35% |
0 |
(0.0%) |
|
| 40% |
0 |
(0.0%) |
|
| 50% |
2 |
(2.9%) |
|
| >50% |
2 |
(2.9%) |
|
| I would participate in a multi-centre randomized controlled study assessing different antibiotic regimens in long-bone reconstruction for tumor surgery. | Yes |
61 |
(87.1%) |
| No | 9 | (12.9%) | |